Clinical trials
Neck Pain trials in Pakistan with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
161 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 13 |
| 2021 | 26 |
| 2022 | 19 |
| 2023 | 26 |
| 2024 | 19 |
| 2025 | 26 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 108 |
| Unknown status | 24 |
| Recruiting | 17 |
| Not yet recruiting | 8 |
| Active, not recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Riphah International University | 104 |
| Foundation University Islamabad | 13 |
| University of Lahore | 11 |
| Dow University of Health Sciences | 4 |
| Superior University | 4 |
| University of Faisalabad | 3 |
| Green International University | 2 |
| Ibadat International University, Islamabad | 2 |
| Lahore University of Biological and Applied Sciences | 2 |
| Shifa Tameer-e-Millat University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neck Pain | 161 |
| Pain | 18 |
| Kinesiophobia | 5 |
| Post-Traumatic Headache | 5 |
| Radiculopathy | 5 |
| Myofascial Pain Syndromes | 4 |
| Chronic Pain | 3 |
| Headache | 3 |
| Shoulder Pain | 3 |
| Muscle Weakness | 2 |
Trials
Showing 1 to 25 of 161. Each trial links to its page on Pharma Observatory.
61 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.